Thanks. You must be an investor but are currently upset over the PR. I believe that the Swiss company who will conduct an audit of the result will help determine the future of AMBS.
IMHO this was initiated by requests from big pharma or deep pockets before they would invest in a JV or a buyout.
As long as I would love a buyout yesterday, I would not mind to turn my investment into a LONG term capital gain as I have years of stock losses. If we do not get a buyout and the clinical trials for the blood test for PD and or Alzeimer are commercialized, they will get this stock close to 1 dollar which will be fine for me. I hope longs will be patient like I am.
Market Data 
Markets 
AI
